From Medscape Oncology

Coverage from the

San Antonio Breast Cancer Symposium (SABCS) 2019

December 11 - 14, 2019; San Antonio, Texas

December 11 - 14, 2019 San Antonio, Texas
  • SABCS 2019 Paclitaxel Pill Tops IV Form, but Needs 9-Hour Fast Among women with metastatic breast cancer, use of an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form, but administration was unique and time-consuming.
  • SABCS 2019 Ten-Year Results Support Partial Breast Irradiation A current phase 3 trial showed that partial breast irradiation — as opposed to irradiating the whole breast — could be a viable alternative in patients with early, low-risk breast cancer.
  • SABCS 2019 Failed ATEMPT: T-DM1 No Safer in Early HER2+ Breast Cancer Trastuzumab emtansine showed no disease-free survival or safety advantage over paclitaxel + trastuzumab in the adjuvant setting for patients with stage 1 HER2-positive breast cancer.

Meeting Highlights At A Glance

  • Top News From SABCS 2019: Slideshow Top News From SABCS 2019: Slideshow Hot topics include a likely new standard in pretreated HER2-positive metastatic disease, a 'major' new finding in triple-negative breast cancer and 'remarkable' new data on menopausal hormone therapy.

Conference News

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Oncology Insights

 

Medscape Oncology Perspectives

Popular News from SABCS 2018

  • Go Low With Tamoxifen for DCIS Go Low With Tamoxifen for DCIS In a potentially practice-changing result, use of a 5-mg daily dose of tamoxifen for patients with ductal carcinoma in situ (DCIS) prevented new and recurrent breast cancer events in comparison with placebo.
  • Major Trial: Partial Breast Radiation Good for Early Breast Cancer Major Trial: Partial Breast Radiation Good for Early Breast Cancer Partial breast irradiation was almost equivalant to whole-breast irradiation for disease control and can be considered a valid treatment option for women with early-stage breast cancer.
  • Free Beer, Wine After Alcohol Warning at Cancer Meeting Free Beer, Wine After Alcohol Warning at Cancer Meeting On opening night, an epidemiologist told meeting attendees that any alcohol intake was associated with an increased breast cancer risk. The next night, the organizers provided free beer and wine to attendees.

Previous Coverage